Healthcare entity
medical-devices is the sole category represented across all 1 tracked stories. ClearPoint Neuro is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window.
Last mentioned: Mar 18, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
medical-devices is the sole category represented across all 1 tracked stories. ClearPoint Neuro is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window. Their average consequence score of 5 runs below the beat's 5.8 for that window. We currently track 1 Healthcare story that mention Danilo D’Alessandro, all published on March 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 24 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Danilo D’Alessandro. Shared-story counts are live from our verified record — not editorial picks.
ClearPoint Neuro reported a 17.8% year-over-year revenue increase for 2025, reaching $37 million, bolstered by the acquisition of Eris Holdings and growth in its biologics segment. Despite rising operational expenses and integration costs, the company demonstrated strong momentum in its neurosurgery navigation and drug delivery platforms.
Source: Motley Fool Transcribing (us) · fool.com
Danilo D’Alessandro is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
